Investigation of the susceptibility of clinical infection loads to nitric oxide antibacterial treatment

被引:0
|
作者
Bright, Lori M. Estes [1 ]
Mondal, Arnab [1 ]
Pinon, Vicente [2 ]
Kumar, Anil [1 ]
Thompson, Stephen [1 ]
Brisbois, Elizabeth J. [1 ]
Handa, Hitesh [1 ,2 ]
机构
[1] Univ Georgia, Coll Engn, Sch Chem Mat & Biomed Engn, Athens, GA 30602 USA
[2] Univ Georgia, Coll Pharm, Pharmaceut & Biomed Sci Dept, Athens, GA 30602 USA
来源
NITRIC OXIDE-BIOLOGY AND CHEMISTRY | 2025年 / 154卷
基金
美国国家卫生研究院;
关键词
Nitric oxide; Antibacterial; Clinical infection; Medical device; S-nitroso- N-Acetylpenicillamine (SNAP); NITROSO-N-ACETYLPENICILLAMINE; STAPHYLOCOCCUS-AUREUS; NANOPARTICLES; PREVENTION; CATHETERS; RELEASE; POLYMER; SNAP;
D O I
10.1016/j.niox.2024.11.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The persistent infection of medical devices by opportunistic pathogens has led to the development of antimicrobial medical device polymers. Nitric oxide (NO) is an endogenous antimicrobial molecule that is released through the degradation of synthetic donor molecules such as S-nitroso- N-acetylpenicillamine (SNAP) embedded into polymer membranes. It is hypothesized that the clinical success of these polymers is enhanced by the physiological release of NO and the consequent prevention of infection. However, such NO-releasing materials have never been evaluated against microbial loads that are commensurate with clinical infection levels. This study aimed to develop a standardized polymer film impregnated with SNAP that consistently releases NO and evaluates its efficacy against bacterial loads that represent clinical infection parameters. Microbial loads of 10(3), 10(5), and 10(8) (colony-forming units) CFU mL(- 1) were exposed to the NO-releasing polymer, corresponding to bloodstream infections, catheter-associated urinary tract infections, and standard laboratory exposure levels that have been reported in the scientific literature. By 24 h, SNAP films led to >1 log reduction of adhered and viable E. coli at all tested microbial loads compared to control polydimethylsiloxane (PDMS). Further, SNAP films displayed no viable adhered S. aureus at the 10(3) microbial level for the entire study and showed total planktonic killing by 8 h. NO localization within bacterial cells adhering to the films was evaluated, revealing higher NO uptake and consequent bacterial killing by SNAP samples. This unique study shows that NO-releasing polymers not only kill bacteria adhered to the polymer surface, but localized delivery leads to environmental planktonic bacterial killing that prevents adhesion from occurring. Furthermore, the promising findings of NO-releasing polymers in scientific research indicate their potential for successful application in clinical settings to prevent infections.
引用
收藏
页码:19 / 28
页数:10
相关论文
共 50 条
  • [21] Cytotoxicity and Antibacterial Activity of Alginate Hydrogel Containing Nitric Oxide Donor and Silver Nanoparticles for Topical Applications
    Urzedo, Alessandro L.
    Goncalves, Marcelly C.
    Nascimento, Monica H. M.
    Lombello, Christiane B.
    Nakazato, Gerson
    Seabra, Amedea B.
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2020, 6 (04) : 2117 - 2134
  • [22] Protective function of nitric oxide in murine Salmonella infection
    Alam, MS
    Akaike, T
    Maeda, H
    BIOLOGICAL RESPONSE TO PLANNED AND UNPLANNED INJURIES: CELLULAR, MOLECULAR AND GENETIC ASPECTS, 2003, 1255 : 257 - 264
  • [23] Susceptibility of Gram-positive and -negative bacteria to novel nitric oxide-releasing nanoparticle technology
    Friedman, Adam
    Blecher, Karin
    Sanchez, David
    Tuckman-Vernon, Chaim
    Gialanella, Philip
    Friedman, Joel M.
    Martinez, Luis R.
    Nosanchuk, Joshua D.
    VIRULENCE, 2011, 2 (03) : 217 - 221
  • [24] Antibacterial MoS2/CaCO3 Nanoplatform for Combined Photothermal, Photodynamic, and Nitric Oxide Therapy
    Jin, Weihao
    Wu, Yujia
    Li, Wanzhen
    Wang, Jun
    Yang, Kai
    Song, Ping
    Zhu, Longbao
    Zhang, Weiwei
    Gui, Lin
    Ge, Fei
    ACS APPLIED NANO MATERIALS, 2023, 6 (20) : 18880 - 18891
  • [25] The effect of five antibacterial agents on the physiological levels of serum nitric oxide in mice
    Barsoumian, Hampartsoum
    El-Rami, Fadi
    Abdelnoor, Alexander M.
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2011, 33 (04) : 652 - 655
  • [26] Quantitative Modeling Extends the Antibacterial Activity of Nitric Oxide
    Sivaloganathan, Darshan M.
    Brynildsen, Mark P.
    FRONTIERS IN PHYSIOLOGY, 2020, 11
  • [27] Clinical applications of nitric oxide
    Mizutani, T
    Layon, AJ
    CHEST, 1996, 110 (02) : 506 - 524
  • [28] Synthesis and Antibacterial Activity Investigation of Novel Cuprous Oxide-Graphene Oxide Nanocomposites
    Huang, Hua
    Velmurugan, Murugan
    Kesavan, Manibalan
    Zhang, Qiang
    Lu, Xinling
    Wang, Yong
    Lin, Jin-Ming
    CHEMISTRY LETTERS, 2020, 49 (06) : 693 - 696
  • [29] Role of nitric oxide in salmonella infection
    Ghosh J.
    Indian Journal of Clinical Biochemistry, 2012, 27 (3) : 306 - 308
  • [30] Dynamic nitric oxide/drug codelivery system based on polyrotaxane architecture for effective treatment of Candida albicans infection
    Li, Guowei
    Lv, Kai
    Pan, Xiangjun
    Zhou, Siting
    Xing, Hui
    Xu, Jun
    Ma, Dong
    Hu, Yunfeng
    Xu, Hao
    ACTA BIOMATERIALIA, 2023, 155 : 618 - 634